Quantitative evaluation of prostatectomy for benign prostatic hypertrophy under a national health insurance law: A multi-centre study

Journal of Evaluation in Clinical Practice

Volumn 8, Issue 1, 2002, Pages 9-18

  Pilpel, D ^a   Porath, A ^a,b   Peleg, A ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Benign prostatic hypertrophy; Case mix of patients; Prostatectomy; Quality of care; Regional variation

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER; CHRONIC DISEASE; CLINICAL TRIAL; CONFIDENTIALITY; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; HEALTH CARE QUALITY; HEALTH INSURANCE; HUMAN; ISRAEL; KIDNEY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; POSTOPERATIVE COMPLICATION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; PROSTATECTOMY; PROSTATISM; QUESTIONNAIRE; SURGICAL TECHNIQUE; SURGICAL WARD;

AGED; ANALYSIS OF VARIANCE; HUMANS; ISRAEL; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; NATIONAL HEALTH PROGRAMS; OUTCOME ASSESSMENT (HEALTH CARE); POSTOPERATIVE COMPLICATIONS; PROSTATECTOMY; PROSTATIC HYPERPLASIA; SEVERITY OF ILLNESS INDEX;

EID: 0036118613     PISSN: 13561294     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2753.2002.00318.x     Document Type: Article

References (43)

1. Geographic variations in utilization rates in Veterans Affairs hospitals and clinics
2. A nationwide survey of practicing urologists: Current management of benign prostatic hyperplasia and clinically localized prostate cancer
3. The American Urological Association symptom index for benign prostatic hyperplasia
4. Management of benign prostatic hyperplasia
5. Benign prostatic hyperplasia specific health status measures in clinical research: How much change in the American Urological Association Symptom Index and the Benign Prostatic Hyperplasia Impact Index is perceptible to patients?
6. Regional variation in intervention rates: What are the implications for patient selection?
7. The International Prostrate Symptom Score in a community-based sample of men between 55 and 74 years of age. Prevalence and correlation of symptoms with age, prostate volume, flow rate and risidual urine volume
8. Should hepatic resections be performed at high-volume referral centers?
9. Indications for treatment of benign prostatic hyperplasia. The American Urological Association study
10. Instruments for quality assurance in centers for medical rehabilitation
11. Hospital volume influences outcome in patients undergoing pancreatic resection for cancer
12. Diagnostic values and limitations on conventional urodynamic studies (uroflowmetry residual urine measurement cystometry) in benign prostatic hypertrophy
13. The importance of co-existent disease in the occurrence of postoperative complication and one-year recovery in patients undergoing total hip replacement. Comorbidity and outcomes after hip replacement
14. Regionalization of cardiac surgery in the United States and Canada. Geographic access, choice, and outcomes
15. Improving the outcomes of coronary artery bypass surgery in New York State
16. Comprehensive patient evaluation for benign prostatic hyperplasia
17. The American Urological Association symptom score in the evaluation of men with lower urinary tract symptoms: At 2 years of follow-up, does it work?
18. The relationship between coronary angioplasty procedure volume and major complications
19. Correlations among prostatic biopsy results, transrectal ultrasound findings and PSA levels in diagnosing prostate adenocarcinoma
20. Differences in the mix of patients among medical specialties and systems of care. Results from the medical outcomes study
21. Comparing comorbid-illness indices assessing outcome variation: The case of prostatectomy
22. Epilepsy treatment in the Netherlands. Comparison of matched groups of two medical centers
23. Early detection of prostrate cancer in Germany: A study using digital rectal examination and 4.0 ng/ml prostate-specific antigen as cutoff
24. An assessment of radical prostatectomy. Time trends, geographic variation, and outcomes
25. Benign prostatic hyperplasia: Diagnosis and treatment
26. Compliance with US asthma management guidelines and specialty care: A regional variation or national concern?
27. Examination for indication of systematic biopsy for diagnosis of prostate cancer
28. Transurethral water-induced thermotherapy for treatment of benign prostatic hyperplasia: A prospective multicenter clinical trial
29. Quality of care for patients hospitalized with heart failure at academic medical centers
30. The effect of hospital volume on the in-hospital complication rate in knee replacement patients
31. Innovative uses of a cardiothoracic database
32. A regional prospective study of in-hospital mortality associated with coronary artery bypass grafting
33. Influence of age and hospital volume on results of carotid endarterectomy: A statewide analysis of 9918 cases
34. The Hytrin Community Assessment Trial study: A one-year study of terazosin versus placebo in the treatment of men with symptomatic benign prostatic hyperplasia
35. The role of cystoscopy before radical prostatectomy
36. Comparison of percutaneous transluminal coronary angioplasty outcome and hospital costs for low-volume and high-volume operators
37. Outcomes of transrectal ultrasound scan of the prostate with sector biopsies for 323 New Zealand men with suspicion of prostate cancer
38. Variations in 'avoidable' mortality: A reflection of variations in incidence?
39. The hospital volume-outcome relationship in general thoracic surgery. Is the surgeon the critical determinant?
40. An evaluation of radical prostatectomy at veterans affairs medical centers. Time trends and geographical variation in utilization and outcomes
41. How consumer assessments of managed care vary within and among markets
42. Contribution of databases to regional and supra-regional quality improvement in rheumatologic treatment and patient management